Wednesday, July 8, 2026

pharma · Chronic Kidney Disease Requiring Chronic Dialysis · UNCY

Unicycive Therapeutics

Unicycive Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Los Altos, USA HQ
2016 Founded
23 Employees
Public company Type
UNCY · NYSE Ticker
Company details
Status
Public
HQ
Los Altos, USA
Founded
2016
Employees
23
Programs
1
Drugs
3
Patents
4
Intelligence · Clinical Programs

Unicycive Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Unicycive Therapeutics.

Unicycive Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Oxylanthanum Carbonate

    Unicycive Therapeutics

    Chronic Kidney Disease Requiring Chronic Dialysis

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Unicycive Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.